Clinical trial
An Open Label, Three Arm, Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care vs. Oral Levofloxacin vs. Combined Therapy for Mild Diabetic Foot Infections
NCT00516958 is registered in ClinicalTrials.gov with Oculus Innovative Sciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Three Arm, Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care vs. Oral Levofloxacin vs. Combined Therapy for Mild Diabetic Foot Infections
- Lead sponsor
- Oculus Innovative Sciences, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- December 31, 2007
- Enrollment
- 65 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
foot ulcer, diabetic